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Abstract: Background: The demand for assessing health-related quality of life (HRQoL) in chronic
otitis media (COM) is increasing globally. The currently available Chinese-language patient-reported
outcome measurement (PROM) specific for COM includes merely a limited range of related symptoms
and dimensions. Hence, in this study, we aim to translate, culturally adapt, and validate the Zurich
Chronic Middle Ear Inventory (ZCMEI-21) in Chinese, to enable a comprehensive evaluation of the
patients’ subjective health outcome in COM. Methods: We sampled and surveyed 223 COM patients
at three tertiary referral centers in China, using the Chinese translation of ZCMEI-21 (ZCMEI-21-Chn)
and the EQ-5D questionnaire, a generic measure of HRQoL. Confirmatory factor analysis (CFA) was
performed to investigate the structural model fit to the dataset. Cronbach’s ฀ and test-retest reliability
coefficient were calculated to establish reliability, and correlation was tested between ZCMEI-Chn scores
and EQ-5D scores for convergent validity. Results: A total of 208 adult patients with COM were included,
with a mean age of 46 years (SD 14 years) and a male proportion of 41% (85/208). A modified bifactor
model with ฀H of 0.65 and ECV of 0.47 was found to fit the scale scores, indicating fair general factor
saturation and multidimensionality of the instrument. ZCMEI-21-Chn demonstrated good reliability
(Cronbach’s ฀ = 0.88, test-retest reliability = 0.88). The total scores of ZCMEI-21-Chn had a moderate
correlation with a question directly addressing HRQoL (r = 0.40, p < 0.001), EQ-5D descriptive system
score (r = 0.57, p < 0.001), and EQ-5D visual analogous scale (r = 0.30, p < 0.001). Conclusions: The
ZCMEI-21-Chn is valid, reliable and culturally adapted to Chinese adult patients with COM. This study
offers clinicians an efficient and comprehensive instrument to quantify COM patients’ self-reported health
outcomes, which could facilitate the standardization of HRQoL data aggregation in COM on a global
scale.
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Abstract
Background: The demand for assessing health-related quality of life (HRQoL) in chronic otitis media (COM) is
increasing globally. The currently available Chinese-language patient-reported outcome measurement (PROM)
specific for COM includes merely a limited range of related symptoms and dimensions. Hence, in this study, we aim
to translate, culturally adapt, and validate the Zurich Chronic Middle Ear Inventory (ZCMEI-21) in Chinese, to enable
a comprehensive evaluation of the patients’ subjective health outcome in COM.
Methods: We sampled and surveyed 223 COM patients at three tertiary referral centers in China, using the Chinese
translation of ZCMEI-21 (ZCMEI-21-Chn) and the EQ-5D questionnaire, a generic measure of HRQoL. Confirmatory
factor analysis (CFA) was performed to investigate the structural model fit to the dataset. Cronbach’s α and test-
retest reliability coefficient were calculated to establish reliability, and correlation was tested between ZCMEI-Chn
scores and EQ-5D scores for convergent validity.
Results: A total of 208 adult patients with COM were included, with a mean age of 46 years (SD 14 years) and a
male proportion of 41% (85/208). A modified bifactor model with ωH of 0.65 and ECV of 0.47 was found to fit the
scale scores, indicating fair general factor saturation and multidimensionality of the instrument. ZCMEI-21-Chn
demonstrated good reliability (Cronbach’s α = 0.88, test-retest reliability = 0.88). The total scores of ZCMEI-21-Chn
had a moderate correlation with a question directly addressing HRQoL (r = 0.40, p < 0.001), EQ-5D descriptive
system score (r = 0.57, p < 0.001), and EQ-5D visual analogous scale (r = 0.30, p < 0.001).
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Conclusions: The ZCMEI-21-Chn is valid, reliable and culturally adapted to Chinese adult patients with COM. This
study offers clinicians an efficient and comprehensive instrument to quantify COM patients’ self-reported health
outcomes, which could facilitate the standardization of HRQoL data aggregation in COM on a global scale.
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Background
Chronic otitis media (COM) is a long-term inflammation
of the middle ear and mastoid air cells, characterized by
recurrent purulent discharge through the tympanic per-
foration. According to the WHO [1], China has a preva-
lence of COM ranging from 0.5 to 4%. A significant
proportion of the population developed chronic condition
as a sequel to acute otitis media (AOM) in their early
childhood, and thus suffered from prolonged and cumula-
tive impacts of the disease [2].
COM not only afflicts patients with recurrent or unremit-
ting ear symptoms, including aural drainage, varying degree
of hearing impairment etc., but also affects their mental
state by generating anxiety or even social alienation [3].
Disturbed health-related quality of life (HRQoL) often com-
plicate patients’ perspectives on the treatment outcome,
which may not necessarily be consistent with the physi-
cians' [4]. Therefore, patients’ participation in evaluation
should be valued as important supplements to physicians’
viewpoints and physiological evidence. To study HRQoL,
patient-reported outcome measures (PROMs) are often
used as the assessment tools. These validated question-
naires with clinimetric and psychometric paradigms allow
direct and comprehensive descriptions from the patients on
their health conditions, and can be applied in both clinical
practice and research settings [5, 6].
Currently, the Chinese version of the Chronic Ear Survey
(CCES) [7] adapted from the original English Chronic Ear
Survey (CES) [8] has been validated and applied nationwide
as a Chinese-language PROM to evaluate HRQoL of adult
patients with COM [9]. This 13-item questionnaire helps
physicians to investigate the health consequences and treat-
ment effectiveness in COM cases from three dimensions: i.
Activity Restriction, ii. Symptoms and iii. Medical Re-
sources Utilization [8]. The construction and certain items
of CES have been referred to by several new instruments
[10–12]. However, the CES does not involve any questions
regarding the onset of tinnitus or psychological bearings
[13], which are common COM patient complaints that
might seriously compromise their HRQoL [3]. Recently, the
Zurich Chronic Middle Ear Inventory (ZCMEI-21) [10] has
been developed, which is a new questionnaire enabling a
comprehensive evaluation of HRQoL. The ZCMEI-21 is
subcategorized into four subscales: i. Ear Signs and Symp-
toms, ii. Hearing, iii. Psychosocial Impact, and iv. Medical
Resources. Each subscale contains questions evaluating
somatic or psychosocial outcomes scaling from 0 (absence)
to 4 (extreme severity).
There has been an increasing need for a universal,
disease-specific PROM by worldwide researchers [13–
15]. Instruments applicable to different cultural settings
allow for consistent trans-national data compilation and
comparison. To standardize the reporting of quality-of-
life outcomes in COM, the original German ZCMEI-21
has already been adapted into Japanese [16], English [17]
and Italian versions [18]. The aims of this present study
are to translate the ZCMEI-21 into Chinese (ZCMEI-21-
Chn) and validate the Chinese-language instrument in
the cultural context.
Methods
Patients and study centers
Inclusion criteria were i. diagnosis of COM with or with-
out cholesteatoma (otitis media chronica cholesteatoma-
tosa [OMCC] and/or otitis media chronica simplex
[OMCS]), ii. adult age, iii. Mandarin Chinese as native
language. A total of 223 patients were recruited via con-
venience sampling to complete the ZCMEI-21-Chn,
along with the EQ-5D-5L questionnaire, during their
outpatient visits at three referral centers between No-
vember 2018 and January 2019. Of the 223, 15 were ex-
cluded due to missing data, which leaves a total of 208
(93.3%) patients included in this present study (Depart-
ment of Otolaryngology - Head and Neck Surgery, Pe-
king University Third Hospital, Beijing, PR China: n =
61; Department of Otorhinolaryngology Head and Neck
Surgery, People’s Liberty Army General Hospital,
Beijing, PR China: n = 71; Department of Otorhinolaryn-
gology, Tongren Hospital, Beijing, PR China: n = 76).
The detailed study design and inclusion criteria are de-
scribed in Fig. 1.
Translation process
By referring to the ISPOR Principles of Good Practice
[19], we standardized the translation and cultural adap-
tion process into the forward, backward, and pretest
steps, similar to the procedure of other ZCMEI-21 valid-
ation studies (see Fig. 1). The original inventory was pri-
marily translated by two authorized translators
independently. A native Chinese-speaking otologist with
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high proficiency in German then revised and merged
these two transcriptions into a reconciled version,
ZCMEI-21-Chn v1. A pilot test on v1 was conducted by
5 subjects, followed by cognitive debriefing and consen-
sus meeting with the development team, though not ex-
plicitly recommended by ISPOR. V1 was then modified
into ZCMEI-21-Chn v2 based on the feedbacks from the
respondents. A third professional translation agency with
medical background later translated ZCMEI-21-Chn v2
back into German. Certain items have been culturally
adapted in the back translated version. For instance, on
noticing that a significant proportion of the respondents
were unable to connect their experience of dizziness
with “the loss of balance control” originally stated in
Question 5, we altered the description of this item into
“Have you been experiencing dizziness or loss of bal-
ance?”. The transcription was reviewed against the
original German version and revised for minor differ-
ences, before being subjected to a second cognitive
debriefing process on another 5 subjects with no fur-
ther adjustments. The final version of ZCMEI-21-Chn




The final version of ZCMEI-21-Chn, along with the 5-
level EuroQol five-dimensional questionnaire (EQ-5D-5L
[20], referred to as EQ-5D), was administrated by patients
meeting the abovementioned inclusion criteria at the
clinics. Concurrent audiometric data were obtained from
all the recruited cases. The layout panel from the original
script [10] was adopted in the Chinese version of ZCMEI-
21. For validation purposes, we involved an extra question
directly assessing the general quality of life (Question 22,
“My ear illness is worsening my quality of life…not at all/
mildly/ moderately/ severely/ very severely”).
The EQ-5D is a preference-based instrument used
world-wide [21, 22] to assess generic HRQoL [23], and it
comprises of the EQ-5D descriptive system and the EQ
Visual Analogue Scale (EQ VAS). The former defines
health in terms of 5 dimensions: i. Mobility, ii. Self-Care,
iii. Usual Activities, iv. Pain/Discomfort and v. Anxiety/
Depression; each dimension is depicted at five levels,
corresponding to no, slight, moderate, severe and ex-
treme problems. The latter, EQ VAS, measures the self-
rated health state on the day of interview, ranging from
Fig. 1 Study design for the translation and validation process of ZCMEI-21-Chn
Yang et al. Health and Quality of Life Outcomes          (2020) 18:218 Page 3 of 11
0 to 100 (corresponding to “worst” to “best imaginable
health state”). The Chinese version of the EQ-5D ques-
tionnaire, administrated in the validation study, has been
validated with a full set of rescaled EQ descriptive sys-
tem scores [24], scaling from − 0.391 to 1.
The role that cultural differences play in shaping the
patients’ perception of items originally developed in a
foreign background was taken into consideration during
the process. In addition, the results of the other inter-
national validation studies on the adapted versions of
ZCMEI-21 enlightened us to hypothesize the correlation
between the generic HRQoL scores and the COM-
specific scale scores as moderate and positive.
Quality control was performed throughout the present
study. Participants were provided with detailed verbal and
written instruction on scale filling if needed. Unified train-
ing for standard procedure of recording of the question-
naires was conducted among all researchers. Each
questionnaire was double entered and was checked in time.
Statistical analysis
Statistical analysis was performed using SAS (version 9.4,
SAS Institute Inc., Cary, NC, USA), R Software (version
3.6.3, The R Foundation for Statistical Compupting),
Mplus (version 7.4, Muthén & Muthén, CA, USA) and
GraphPad Software (version 8, GraphPad Software, La
Jolla, CA, USA). A two-tailed p-value less than 0.05 was
considered statistically significant for all analyses. Values
were reported as mean (SD) or as absolute number and
percentage. The frequency distribution of the ZCMEI-21-
Chn total scores was inspected through both a graphical
approach and a normality test. The bell-shaped distribu-
tion fitting a normal probability curve in the histogram,
and a p > 0.05 in D’Agostino-Pearson normality test indi-
cated Gaussian distribution of the data. Items with a value
of item total-correlation (ITC) corrected for overlap ≥0.3
were deemed as a “strong item” [10].
Before structural detection, sampling adequacy was
confirmed via the Kaiser-Meyer-Olkin (KMO) test and
Bartlett’s test of sphericity. A KMO value ≥0.80 and a
p < 0.05 in Bartlett’s test indicated suitability of the data
for factorial analysis. The developer of ZCMEI-21 sug-
gested a hypothesized structure model comprising of 4
dimensions that also supported an overall score of the
scale [10]. Therefore, a bifactor model and a second-
order model was examined through fit indexes via con-
firmatory factor analysis (CFA) [25]. Based on theoretical
considerations and statistical indications, models were
modified to acquire fitting solution. Cutoff levels of fit
indexes were: Root Mean Square Error of Approxima-
tion (RMSEA) < 0.06; both Comparative Fit Index (CFI)
and Non-Normed Fit Index (NNFI), also known as
Tuker-Lewis Index (TLI) > 0.95 [26]. Modified model fit
was reanalyzed to prove statistical superiority over the
original model via a chi-square difference test and com-
parison of AIC and BIC. Coefficient omega hierarchical
(ωH) and explained common variance (ECV) were calcu-
lated to estimate the proportion of variance attributable
to the single general target trait (general factor, G) [27],
and to measure the unidimensionality of the scale [25]
accordingly.
The pure-tone average (PTA) at speech frequency (0.5
kHz, 1 kHz, 2 kHz, and 4 kHz) [28] were collected from
the patient’s concurrent audiometry testing. Criteria val-
idity of ZCMEI-21-Chn was assessed with correlations
to the PTAs of worse- and better-hearing ear.
Convergent validity was established by studying correl-
ation between the total ZCMEI-21-Chn s cores, the add-
itional question (Question 22) that directly addressed
HRQoL the and EQ-5D descriptive system and VAS
scores were examined using Pearson’s correlation ana-
lysis. Cronbach’s α and test-retest reliability suggested
the reliability of the ZCMEI-21-Chn, with acceptance
range set to ≥ 0.70 [7, 29].
The sample size for the validation survey was deter-
mined based on a subject to item ratio of 10:1, i.e.
21*10 = 210 cases [30].
Results
Detailed characteristics of the 208 respondents are listed
in Table 1. Questions 8–10 assessing hearing impair-
ment in detail were automatically skipped by 25 patients
[10], who claimed, in Question 7, no detectable hearing
impairment within the last 2 weeks.
Single item statistics showed well-distributed answers
and full range of answers (0–4) in every question. Detailed
Table 1 Patients Characteristics of the Validation Cohort
Validation Cohort (n = 208)
Male to female ratio 85 (41%): 123 (59%)
Age (years) 46 (14)
COM, type - n%
- OMCS 150 (72%)
- OMCC 51 (25%)
- both 7 (3%)
Affected Ear(s)
- left 92 (44%)
- right 70 (34%)
- both 46 (22%)
Previous surgical history due to COM – n%
yes 37 (18%)
no 171 (82%)
Disease duration (months) 221 (203)
Data are mean (SD) or number (%)
COM chronic otitis media; OMCS otitis media chronica simplex; OMCC otitis
media chronica cholesteatomatosa
Yang et al. Health and Quality of Life Outcomes          (2020) 18:218 Page 4 of 11
descriptive statistics of the individual items and subscales
are listed in Table 2. The Item-Total-Correlation (ITC),
corrected for overlap with the scale total, as one of the cri-
teria for a strong item, was above 0.3 for all items except
question 5 [10]. Correlation among the four subscales
ranges from 0.18 to 0.61 (p < 0.001). Each subscore was
moderately to strongly correlated with the ZCMEI-21-Chn
total scores (see Table 3).
ZCMEI-21-Chn total scores followed a Gaussian dis-
tribution, suggested by both the histogram (Fig. 2) and
the D’Agostino & Pearson normality test (p = 0.06). No
significant differences of ZCMEI-21-Chn total scores
among the three study centers were observed (p = 0.07,
F(2,190) = 2.644, one-way ANOVA; Fig. 3).
By conducting the KMO test and Bartlett’s test of spher-
icity on the data obtained, we found a KMO value of 0.87
and a p-value less than 0.001 respectively. From these re-
sults, we confirmed our data to be suitable to construct in-
vestigation via factorial analysis. The fit statistics of the
hypothesized bifactor model with four domain-specific
factors and the corresponding second-order model with
four lower-order factors were reported in Table 4. The re-
sults of these fit statistics indicated post-hoc modification
to both models. We obtained alternative bifactor and
second-order solutions by deleting Question 5. Among all
observable variables, item q5 was found with the lowest
factor loading to the latent variables, also most poorly
understood by the Chinese patient group. The chi-square
difference test suggested that the modified bifactor model
(Fig. 4) was a statistically better fit (Δχ2(18) = 32.96, p <
0.05) [31, 32] than the hypothesized construct. Also,
RMSEA, NNFI and CFI of the modified bifactor model all
fell within acceptable range, while those of the modified
second-order model did not. Coefficient ωH of the general
factor in the model fit was 0.65, and ECV was 0.47. For
detailed fit statistics and the loading matrix of the hypoth-
esized and the trimmed model, please refer to Tables 4
and 5 and Fig. 4.
Cronbach’s α of ZCMEI-21-Chn was 0.88, with all
subscales’ above 0.70, except for the ear symptoms
Table 2 Descriptive statistics of the individual items (ZCMEI-21-Chn)
Number Subscale/Item Mean Min-Max ITC (adjusted) Cronbach’s α
I. Ear Symptoms and Signs 0.60
1. Ear Pain 0.81 0–4 0.30
2. Discharge 1.80 0–4 0.30
3. Itching 1.27 0–4 0.42
4. Feeling of Pressure 1.68 0–4 0.43
5. Dizziness 0.32 0–4 0.26
II. Hearing 0.77
6. Tinnitus 1.63 0–4 0.32
7. Hearing (filter question) 2.47 0–4 0.47
8. When many people speak at the same time 1.80 0–4 0.57
9. Telephone, alarm clock 1.00 0–4 0.50
10. Fear of not hearing other people 1.77 0–4 0.55
III. Psychosocial Impact 0.86
11. Impact of ear symptoms on HRQoL 2.35 0–4 0.64
12. Activities with family and friends 1.21 0–4 0.64
13. In public (e.g. school/occupation, shopping) 1.39 0–4 0.73
14. Making contact with other people 1.45 0–4 0.70
15. Quality of sleep 1.35 0–4 0.60
16. Sadness 1.63 0–4 0.62
17. Fear that the ear problems may persist 2.31 0–4 0.50
18. Protection from water 1.74 0–4 0.27
IV. Medical Resources 0.71
19. Medical consultations 1.46 0–4 0.31
20. Antibiotics (oral) 1.11 0–4 0.32
21. Ear drops 1.41 0–4 0.37
ITC Item-Total-Correlation
Cronbach’s α for individual subscales
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dimension. There were 53 patients who had not under-
gone significant clinical change from last visit, and were
readministrated with the scale after a three- to four-
week interval. And the test-retest reliability coefficient
was also 0.88.
For validity evaluation, we observed a moderate correl-
ation (r = 0.40, p < 0.001) between the question directly
addressing HRQoL (Question 22) and the total scores of
ZCMEI-21-Chn. The EQ descriptive scores were moder-
ately correlated with the ZCMEI-21-Chn total scores
(r = 0.57, p < 0.001). Yet, a weaker correlation was found
between EQ-5D VAS and the ZCMEI-21-Chn total
scores (r = 0.30, p < 0.0001). Next, the ZCMEI-21-Chn
factor scores were correlated to the EQ-5D scores. Sub-
scale representing the psychosocial impact, was strongly
correlated to the EQ-5D descriptive system scores.
The correlation between the ZCMEI-21-Chn and the
audiometric data were demonstrated in Table 6. Both
worse-hearing ear PTA [53.84 (23.96) dB HL] and better-
hearing ear PTA [25.82 (19.44) dB HL] significantly corre-
lated with the hearing-related items and the total scores.
Lastly, while comparing the total and subscale scores
of ZCMEI-21-Chn, and the EQ-5D descriptive system
score, a good level of comparability to the respective
scores reported in the original validation study was dis-
covered. Table 7 offers an extensive prospect over the
global commonalities of the validation process for the
various ZCMEI adapted versions.
Discussion
In the present study, we translated the ZCMEI-21 into
Chinese by following the international guidelines. Next, we
validated the ZCMEI-21-Chn in a multi-center study.
Cronbach’s α and test-retest reliability coefficient of 0.88 in-
dicated a good level of reliability of the entire questionnaire.
Despite a lack of clear recommendations for the translated
versions of an established scale, α ≥ 0.70 is a commonly
used level for reliable measure in population studies [7].
With sampling adequacy to factor analysis confirmed with
KMO and Barlett’s test, CFA was performed to seek struc-
tural models that fit the data. The results of CFA suggested
that the modified bifactor model provided a significantly
better fit to the matrix than the original hypothesized
models. An ωH of 0.65 provided quantitative evidence that
the scale scores generalize to a relative high extent to a la-
tent variable (general factor, G) common to all the direct
Table 3 Descriptive statistics and correlation of subscales and total scores of ZCMEI-21-Chn
D1 D2 D3 D4
Items involved Question 1–5 Question 6–10 Question 11–18 Question 19–21
Mean 5.88 (3.80) 8.67 (4.77) 13.42 (7.74) 3.98 (2.56)
Correlation to D2 r = 0.30 a
Correlation to D3 r = 0.44 a r = 0.61 a
Correlation to D4 r = 0.37 a r = 0.18 a r = 0.32 b
Correlation Coefficient to ZCMEI-21-Chn total scores r = 0.66 b r = 0.77 b r = 0.91 b r = 0.51b
ZCMEI-21-Chn Chinese version of Zurich Chronic Middle Ear Inventory
a Correlation coefficients were significant at p < 0.001, b Correlation coefficients were significant at p < 0.0001
Fig. 2 ZCMEI-21-Chn total scores distribution and best-fitting
Gaussian curve (bin-width on x-axis: 5) Fig. 3 ZCMEI-21-Chn total scores at the three referral centers
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variables (except item 5). However, the domain-specific fac-
tors account for 53% (1-ECV) of the total variance, indicat-
ing that both an overall scoring and a combination of the
subscores are meaningful interpretations of the scale [33].
Within CFA, the fifth item (q5) that questioned the pa-
tients about their feelings of dizziness or loss of balance
control was already revised for inexplicability during the
prior translation stage. The revised q5 turned out to remain
poorly understood with the lowest loading to both F1(the
symptom dimension, 0.06) and G(general factor, 0.18). The
fit statistics of the model with complete deletion of q5 ex-
cels the one that only removed q5 from F1. Meanwhile,
loading on item 6 (tinnitus) to F2 (hearing dimension) was
0.08, and 0.45 to G in the original bifactor model. We have
also tried to modify the model by subtracting q6 from F2
solely or in combination with deleting q5. However, the fit
indices of both models were found unacceptable, which
suggested that further post-hoc modification would make
neither theoretical nor statistical sense.
Furthermore, item 18 (protection from water)‘s load-
ing to G was lower than the other items included in the
psychsocial dimension (F3). Consistent with the findings
during survey, the daily water-proof precautionary mea-
sures seemed to bother Chinese COM patients far less
Table 4 Fit indices of the hypothesized and the modified models
Models χ2 Δf RMSEA NNFI (TLI) CFI AIC AIC Saturated BIC
Hypothesized Bifactor model 270.83* 168 0.05 0.94 0.94 394.25 − 1098.42 637.89
Second-order model 376.02* 185 0.07 0.87 0.88 468.02 − 1099.06 621.55
Modified Bifactor model 237.25* 150 0.05 0.96 0.95 348.26 − 992.34 581.90
Second-order model 338.93* 181 0.07 0.89 0.88 426.92 − 1071.04 573.78
χ
2 chi-square; Δf degree of freedom; RMSEA Root Mean Square Error of Approximation; NNFI Non-Normed Fit Index, also known as TLI Tuker-Lewise Index; CFI
Comparative Fit Index; AIC Akaike Information Criteria; BIC Bayesian Information Criterion
*: p < 0.001
Fig. 4 Modified bifactor model that best fits the data
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than the inconvenience brought by ear drainage or hear-
ing impairment. Quite commonly did these patients re-
spond to item 18 with “I have got used to wearing these
earplugs during showers” or “It’s fine that I have quitted
swimming ever since the onset of the disease”. Such dis-
coveries that may involve a role of cultural ambiance in-
spire the interests and efforts in our future studies.
In addition, the fourth dimension (medical resources)
demonstrated good internal reliability, yet showed the weak-
est correlation to both ZCMEI-21-Chn total scores and EQ-
5D scores, as well as a non-significant correlation to PTA of
either better- or worse-hearing ear. On one hand, this may
suggest that seeking treatment played a comparatively lim-
ited part in hampering the general HRQoL in Chinese
COM patients; on the other hand, the frequency of clinic
appointments and medicine usages might not only be
affected by the severity of hearing impairment or other
complications, but also by the uneven distribution and ac-
cessibility of medical resources across the country.
A moderate correlation between total scores and the
question directly addressing HRQoL might be explained
by the underlying variance in perception and requirement
of living standard in the Chinese cultural background.
Weak to moderate correlation between the ZCMEI-21-
Chn total, subscale scores and EQ-5D scores were well
within expectation, since generic PROMs are reportedly
less sensitive to self-rated HRQoL than disease-specific
measures in hearing impaired or COM patients [34, 35].
Noticeably, correlation to the ZCMEI-21-Chn total and
subscale scores of the EQ VAS scores were overall weaker
than that of the EQ-5D descriptive system scores, possibly
implying that the Chinese patients were unfamiliar with
the visual analogous scale for the use of rating their health
state.
Table 5 Factor loadings from the hypothesized and the modified bifactor models of the ZCMEI-21-Chn
Hypothesized Bifactor Model Modified Bifactor Model
Item Subscale/Item G F1 F2 F3 F4 G F1 F2 F3 F4
LE SE LE SE LE SE LE SE LE SE LE SE LE SE LE SE LE SE LE SE
1. Ear Pain 0.29 0.08 0.31 0.11 0.29 0.08 0.31 0.10
2. Discharge 0.28 0.10 0.81 0.12 0.28 0.10 0.81 0.12
3. Itching 0.42 0.08 0.67 0.11 0.42 0.08 0.67 0.11
4. Feeling of Pressure 0.45 0.10 0.81 0.11 0.45 0.09 0.81 0.11
5. Dizziness 0.18 0.07 0.06 0.07
6. Tinnitus 0.45 0.10 0.08 0.11 0.44 0.09 0.09 0.11
7. Hearing (filter question) 0.60 0.10 0.61 0.09 0.60 0.08 0.61 0.09
8. When many people speak
at the same time
0.81 0.09 0.97 0.10 0.81 0.08 0.97 0.10
9. Telephone, alarm clock 0.58 0.10 0.56 0.09 0.57 0.09 0.56 0.09
10. Fear of not hearing other
people
0.83 0.09 0.35 0.09 0.83 0.09 0.36 0.09
11. Impact of ear symptoms
on HRQoL
0.78 0.09 0.37 0.11 0.78 0.09 0.37 0.11
12. Activities with family and
friends
0.94 0.08 0.13 0.13 0.94 0.08 0.13 0.13
13. In public (e.g. school/
occupation, shopping)
1.22 0.07 0.11 0.13 1.22 0.08 0.10 0.12
14. Making contact with other
people
1.19 0.07 0.21 0.11 1.19 0.07 0.20 0.11
15. Quality of sleep 0.77 0.10 0.63 0.12 0.77 0.10 0.64 0.12
16. Sadness 0.92 0.09 0.54 0.14 0.92 0.09 0.55 0.14
17. Fear that the ear
problems may persist
0.76 0.10 0.51 0.12 0.76 0.09 0.51 0.12
18. Protection from water 0.31 0.10 0.44 0.13 0.31 0.10 0.45 0.13
19. Medical consultations 0.21 0.07 0.47 0.07 0.21 0.07 0.47 0.07
20. Antibiotics (oral) 0.24 0.08 0.72 0.10 0.24 0.08 0.72 0.10
21. Ear drops 0.33 0.09 0.82 0.11 0.33 0.09 0.82 0.11
G: general factor; F1: Factor 1; F2: Factor 2; F3: Factor 3; F4: Factor 4
LE Factor loading estimates; SE: Standard error
Yang et al. Health and Quality of Life Outcomes          (2020) 18:218 Page 8 of 11
Although no statistical comparison was performed,
qualitative comparison revealed that the ZCMEI-21-Chn
scored higher both overall and in each subset than the
original German-language ZCMEI-21, as well as the
other international adapted versions. This might be at-
tributable to the relative scarcity of the primary care ac-
cessible to the Mandarin speaking population. In which
case, only patients in a rather progressive state of the
disease would come to seek professional help at the ter-
tiary referral center in the capital. Thus, to assess the
baseline ZCMEI-21-Chn scores of the Chinese COM
population in order to compare with the other
countries’, requires larger-scaled and more representa-
tive sampling in future studies.
There are a number of limitations in this study that
ought to be acknowledged. First, EQ-5D was applied to
the testing of convergent validity of ZCMEI-21-Chn, yet
none to studying the hetrerotrait correlations in discrim-
inant validity. Nonetheless, to administrate extra question-
naires during clinical visits at China’s overloaded tertiary
referral centers seems infeasible. Future efforts will be de-
voted to issuing extended versions of ZCMEI-21-Chn ap-
plicable on the electric devices to allow comprehensive
assessment and better experience of the patients.
Table 7 Descriptive statistics and correlation of the ZCMEI-21-Chn and the EQ-5D-5L, Cronbach’s α in the present study and the
original validation study of the German-language ZCMEI-21, ZCMEI-21-Jap, ZCMEI-21-E, ZCMEI-21-It
Current Study (ZCMEI-21-Chn) ZCMEI-21 [10] ZCMEI-21-Jap [16] ZCMEI-21-E[17] ZCMEI-21-It [18]
ZCMEI-21 total score (SD) 32.0 (14.5) 29.7 (16.1) 25.2 (11.8) 25.9 (15.8) 29.8 (14.6)
I. Ear signs and symptoms 5.9 (3.8) 5.1 (3.9) 2.3 (2.0) 4.2 (3.9) 5.5 (4.5)
II. Hearing 8.7 (4.8) 8. 5 (5.2) 7.6 (5.1) 8.2 (5.1) 7.6 (5.1)
III. Psychosocial impact 13.4 (7.7) 13.1 (7.9) 8.2 (6.6) 10.9 (7.9) 13.7 (7.8)
IV. Medical resources 4.0 (2.6) 3.0 (2.3) 3.0 (2.4) 2.6 (2.4) 2.9 (2.7)
EQ-5D-5L (SD)
Descriptive system score 0.84 (0.17) 0.92 (0.14) 0.89 (0.15) 0.80 (0.23) 0.84 (0.15)
VAS score 77.1 (13.7) N/A 77.3 (16.6) 79.0 (19.7) 76.6 (15.0)
Total score correlation
To question directly assessing HRQoL r = 0.40 a r = 0.74 a r = 0.68 a r = 0.74 a r = 0.62 a
To EQ-5D-5L descriptive system score r = 0.57 a r = 0.60 a r = 0.49 a r = 0.60 a r = 0.39 a
Cronbach’s α 0.88 0.91 0.85 0.91 0.86
ZCMEI-21-Chn = Chinese version of Zurich Chronic Middle Ear Inventory
ZCMEI-21-Jap = Japanese version of Zurich Chronic Middle Ear Inventory
ZCMEI-21-E = English version of Zurich Chronic Middle Ear Inventory
ZCMEI-21-It = Italian version of Zurich Chronic Middle Ear Inventory
EQ-5D-5 L = EuroQol five-dimensional questionnaire in its five-level version
Data are mean (SD)
a Correlation coefficients were significant at p < 0.001
Table 6 Correlation between ZCMEI-21-Chn and audiometric data
Worse-hearing ear PTA Better-hearing ear PTA
Dimensions Hearing-related items r p r p
6 Tinnitus 0.12 < 0.05 0.14 < 0.05
7 Hearing (filter question) 0.41 * < 0.05 0.28 * < 0.05
8 When many people speak at the same time 0.48 * < 0.05 0.39 * < 0.05
9 Telephone, alarm clock 0.38 * < 0.05 0.36 * < 0.05
10 Fear of not hearing other people 0.32 * < 0.05 0.31 * < 0.05
I Ear signs and symptoms 0.17 * < 0.05 0.22 * < 0.05
II Hearing 0.45 * < 0.05 0.39 * < 0.05
III Psychosocial impact 0.35 * < 0.05 0.39 * < 0.05
IV Medical resources 0.06 * 0.3175 0.09 0.1676
Total score ZCMEI-21-Chn 0.40 * < 0.05 0.38 * < 0.05
*: Correlation coefficients were significant at p < 0.05
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The assumptions, under which Cronbach’s α is a con-
sistent estimator for reliability, may not be entirely attain-
able in this study. For example, the varying factor loadings
in the model fits were contrary to tau equivalence. Corre-
lated error might arise from the order of items on the
scale, speeded tests and so on [36]. Moreover, the multidi-
mensionality and the Pearson correlation matrix may also
bias the estimates of Cronbach’s α. On account of these
unrealistic assumptions, a 5-level Likert, multidimensional
scale like ZCMEI-21-Chn, may require substitute indica-
tors for internal consistency, e.g. McDonald’s Omega or
coefficients in G-Theory in future researches. Cronbach’s
α was kept in the present study, also for the parametric
comparison with the other international versions of
ZCMEI-21.
Another limitation to our study is that, without differ-
ent item functioning (DIF), the statistical results re-
ported in this article may only serve as a rough guide to
measure the relationship of this current study with the
original research. Additionally, the sampling was neither
randomized nor representative, rather purposive, which
possibly resulted in the heterogeneity of the subjects, e.g.
in ethnicity or education level. To further adapt ZCMEI-
21-Chn, additional studies are needed focusing on balan-
cing the potential ethnic influence.
Conclusion
We translated and culturally adapted the ZCMEI-21 into
Chinese, and demonstrated the ZCMEI-21-Chn to be a
reliable and valid self-reported outcome measure. Scores
of the entire scale as well as of each dimension can be
used to evaluate HRQoL in adult Chinese patients with
COM. With health professionals’ understanding of the
disease impacts and treatment effectiveness deepened,
our future efforts include implementing the electronic
version of ZCMEI-21-Chn as clinical routine, and en-
hancing standardized data aggregation on a global scale.
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